No FDA approval? No partnership? NO sustained price rise. Unfortunately, the market views SI as the Boy who Cried "Wolf!"
Anyone betting on any real price action before Novartis completing, another partnership being announced, and/or OTAT signing off on the assays--and really, a refiled BLA being APPROVED to permit sales of Ryoncil, is setting themselves up for disappointment.
It's coming, but we have a few hurdles to cross before it does.
Until then, I will just be happy if we don't sink into the $1.50s again!
Ann: MSB Q1 Financial Results and Operational Highlights, page-44
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |